Endovascular

Implementation Science in PAD: Can We Do Better?

9 min.

BEST-CLI and BASIL 2: How Should Findings Impact Care?

23 min.

Increasing Diversity in Peripheral Vascular Disease Research: The Elegance Registry

21 min.

Individual Patient-data Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure at 6 Months in the RADIANCE Clinical Trial Program

20 min.

LIFE-BTK: The Top Line Results and Beyond

21 min.

Real World Experience of Contemporary Pulmonary Embolism Treatment (USCDT versus MT): Insights From Big Data Analytics (REAL-PE)

18 min.

Percutaneous Transmural Bypass for Long and Complex Femoropopliteal Lesions: Clinical Outcomes of the DETOUR-2 Study

14 min.

FDA Opinion About Lessons Learned From the Paclitaxel Controversy

16 min.

Patient-Level Meta-analysis on Paclitaxel Safety

9 min.

Vascular Drug Delivery: Distilling the Paclitaxel Controversy

10 min.

Combination Therapy and Patient Outreach to Improve Adherence to Pharmacotherapies

10 min.

Increasing Diversity in Peripheral Vascular Disease Research: The Elegance Registry

7 min.

Dietary and Lifestyle Approaches to Hypertension Management: What’s New and What’s Changed

10 min.

Opportunities to Improve Outcomes: IVUS

5 min.

Clinical RV Assessment in PE: Is it Hocus Pocus or Can We Standardize Echo Parameters?

10 min.

Hemodynamics of PE: Modeling the RV

10 min.

PE Risk Stratification in 2022

8 min.

What Do the Patients With CLTI Look Like Today? Insights From LIFE-BTK and BEST CLI

8 min.

Limb Perfusion Technology: Do We Have It Figured Out?

6 min.

Have We Gotten to the Final Word on Paclitaxel Safety?

9 min.

Management of Coronary Artery Disease in CLTI? Is That the Ticket?

7 min.

Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond

8 min.